DL-AP7 is a competitive NMDA antagonist and an anticonvulsant. DL-AP7 blocks the NMDA-induced convulsions and impairs learning performance in a passive avoidance task in mice[1].
Molecular Weight:
225.18
CAS Number:
[85797-13-3]
Formula:
C7H16NO5P
Target:
iGluR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted